9 Jun 2026
Outcomes with GLP-1RAs in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-analysis. (S20.007)Publisher siteNeurology, Cerebral Venous Sinus Thrombosis
UniversitiesMohamed Saad Sayed
Active, last published 2026
In cerebrovascular and carotid artery diseases
Mohamed Saad
Sayed
Scholar“Research focused on Cerebrovascular and Carotid Artery Diseases and adjacent fields.”
Beni-Suef University
Claim Your Profile0
H-index
0
Citations
Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohamed Saad Sayed is a researcher working on Cerebrovascular and Carotid Artery Diseases. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohamed's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cerebrovascular and Carotid Artery Diseases×1
04 · Where I am
Affiliations
Affiliation on published researchBeni-Suef UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works9 Jun 2026
Outcomes with Endovascular Therapies vs. Medical Treatment for the Treatment of Intracranial Artery Stenosis: A Meta-analysis and Time-to-event Analysis of Randomized Controlled Trials (P6-5.003)Publisher siteNeurology, Cerebrovascular and Carotid Artery Diseases
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohamed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you